ZEISS Medical Technology Partners with Aier Eye Hospital Group to Elevate Eye Care with Advanced Technology

Strategic Partnership to Revolutionize Eye Care

In a significant advancement for medical technology and patient care, ZEISS Medical Technology has entered into a strategic agreement with Aier Eye Hospital Group. The partnership was formalized on June 12, 2026, during a signing ceremony held at the Aier Eye Hospital's headquarters in Changsha, Hunan Province, China. This collaboration promises to integrate cutting-edge technology into Aier's facilities through the acquisition and installation of 25 ZEISS VISUMAX 800 femtosecond laser systems across various locations.

Enhancing Surgical Efficiency

The ZEISS VISUMAX 800 represents a pinnacle of innovation in refractive surgery. The deployment of these advanced systems is set to begin later in 2026, aimed at enhancing Aier Eye Hospital's ability to deliver precise and efficient care to patients both domestically and internationally. The strategic agreement underscores a commitment by both organizations to enhance high-quality patient care through innovative technological solutions. Martin Fischer, President and CEO of ZEISS Greater China, stated, "Aier Eye Hospital is one of ZEISS Medical Technology's most important global strategic partners," highlighting the mutual benefits that will emerge from this partnership.

A Partnership Beyond Equipment

This collaboration transcends mere equipment provision. ZEISS and Aier are embarking on a journey to explore deeper collaborative innovations that would support international growth, integrated digital workflows, and the potential use of AI-assisted diagnostics. According to Mr. Li LI, Co-Founder and Global President of Aier Eye Hospital Group, "Our collaboration with ZEISS has long transcended mere equipment procurement. We are jointly exploring comprehensive synergies spanning from clinical management to digital applications."

The introduction of the VISUMAX 800 systems will significantly bolster surgical efficiency and ultimately enhance patient satisfaction. Aier is already known for setting benchmarks in refractive surgery, and the new technology will help further maintain this reputation.